会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method and system for providing VOIP services
    • 提供VOIP服务的方法和系统
    • US09210246B2
    • 2015-12-08
    • US14057119
    • 2013-10-18
    • Michael Rosen
    • Michael Rosen
    • H04L12/66H04M1/253H04M1/2745H04M7/00H04L29/06
    • H04M1/2535H04L65/1046H04M1/274566H04M7/0057H04M7/0069
    • A VOIP service and method is provided which comprises an redirecting dialer device (RDD), which connects a telephone to a POTS circuit. Responsive to DTMF signals from the telephone representative of a long telephone distance number, the RDD intercept the DTMF signals and transits alternative DTMF signals representative of an alternative telephone number of a PSTN/VOIP gateway server. Once connected to the PSTN/VOIP gateway server, the RDD then transmits the DTMF signals associated with the original long distance number. The VOIP gateway server is operative to convert the analog signals from the telephone into digital and packetized VOIP data which is transmitted through a public or private IP-based network to a remote telecommunication device associated with the original long distance telephone number. If the DTMF signals from the telephone are representative of a local telephone number, the RDD is operative to forgo transmitting the alternative DTMF signals.
    • 提供了一种VOIP服务和方法,其包括将电话连接到POTS电路的重定向拨号设备(RDD)。 响应于来自代表长电话距离号码的电话的DTMF信号,RDD拦截DTMF信号并且传送代表PSTN / VOIP网关服务器的替代电话号码的备选DTMF信号。 一旦连接到PSTN / VOIP网关服务器,RDD然后发送与原始长途号码相关联的DTMF信号。 VOIP网关服务器可操作地将来自电话的模拟信号转换为通过公共或专用IP网络传输到与原始长途电话号码相关联的远程电信设备的数字和分组VOIP数据。 如果来自电话的DTMF信号代表本地电话号码,则RDD可操作以放弃传输替代的DTMF信号。
    • 8. 发明申请
    • High throughput biological heart rate monitor that is molecularly determined
    • 分子确定的高通量生物心率监测仪
    • US20070042347A1
    • 2007-02-22
    • US11520527
    • 2006-09-12
    • Michael RosenRichard RobinsonIra CohenHan-Gang Yu
    • Michael RosenRichard RobinsonIra CohenHan-Gang Yu
    • C12Q1/00
    • G01N33/6872A61K38/1709A61K48/00G01N33/5008G01N33/502G01N33/5061
    • This invention provides for a chamber and system designed for use in assaying drug effects on heart rate. The chamber consists of a series of wells, each 3 mm by 3 mm in inner diameter. Cardiac myocytes disaggregated from neonatal animals are plated onto the bottom of each well and grown under standard tissue culture conditions. The chamber holds from 24-96 such wells. When drugs are to be assayed, the cells in each well are loaded with a calcium sensitive dye and the beating rate in each is monitored with a photodiode. Drug is added in graded concentrations to each well, and equilibrated and effects on rate are observed. This construct permits use of a cell based bioassay for the study of drugs or agents that may alter cardiac rate. This invention can be used in high throughput screening of drugs to evaluate/predict their effects on cardiac rate and rhythm. Further provided for by this invention is a A vector which comprises a compound which encode an ion channel.
    • 本发明提供了一种设计用于测定药物对心率的影响的室和系统。 该室由一系列的孔组成,内径为3 mm×3 mm。 将从新生儿动物分解的心肌细胞接种在每个孔的底部并在标准组织培养条件下生长。 该厅拥有24-96个这样的井。 当要测定药物时,每个孔中的细胞装载有钙敏感染料,并且用光电二极管监测每个孔中的搏动速率。 将药物以分级浓度加入每个孔中,并平衡并观察其对速率的影响。 该构建允许使用基于细胞的生物测定法来研究可能改变心率的药物或药剂。 本发明可用于药物的高通量筛选以评估/预测其对心率和节律的影响。 本发明进一步提供的是包含编码离子通道的化合物的A载体。